Summary
The speaker argues that the famous PREDIMED Mediterranean diet study has been overstated.
Key points:
- The widely reported “30% reduction in heart disease” was a relative risk reduction. The absolute benefit was only about 2% over five years.
- The control group was not truly low-fat.
- The Mediterranean groups received free olive oil or nuts, dietitian counseling, recipes, and ongoing support, making it difficult to know whether the benefits came from the diet itself.
- Most of the benefit was from fewer strokes. Heart attacks, cardiovascular deaths, and overall deaths were not significantly reduced.
- The original study was retracted and republished after problems with participant randomization.
The speaker also argues that PREDIMED cannot determine whether a Mediterranean diet reverses arterial plaque because participants generally did not have established coronary artery disease and plaque was never measured.
Bottom line:
According to the speaker, PREDIMED provides moderate evidence that a Mediterranean diet may reduce stroke risk in high-risk individuals, but it does not prove it prevents heart attacks, extends life, or reverses coronary artery disease. Many nutrition and cardiology experts interpret the evidence more favorably, so the debate is about the strength of the evidence rather than whether the diet is beneficial at all.